Jill S. Frank

819 total citations
14 papers, 150 citations indexed

About

Jill S. Frank is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Jill S. Frank has authored 14 papers receiving a total of 150 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Jill S. Frank's work include Cutaneous Melanoma Detection and Management (9 papers), Immunotherapy and Immune Responses (4 papers) and Nonmelanoma Skin Cancer Studies (4 papers). Jill S. Frank is often cited by papers focused on Cutaneous Melanoma Detection and Management (9 papers), Immunotherapy and Immune Responses (4 papers) and Nonmelanoma Skin Cancer Studies (4 papers). Jill S. Frank collaborates with scholars based in United States and Germany. Jill S. Frank's co-authors include David W. Ollila, Michael O. Meyers, Keith D. Amos, Karyn B. Stitzenberg, Nancy E. Thomas, Jen Jen Yeh, Justin Baker, Yi‐Hsuan Tsai, Allison M. Deal and Kathleen Conway and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Jill S. Frank

14 papers receiving 148 citations

Peers

Countries citing papers authored by Jill S. Frank

Since Specialization

Citations

This map shows the geographic impact of Jill S. Frank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill S. Frank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill S. Frank more than expected).

Fields of papers citing papers by Jill S. Frank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill S. Frank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill S. Frank. The network helps show where Jill S. Frank may publish in the future.

Co-authorship network of co-authors of Jill S. Frank

This figure shows the co-authorship network connecting the top 25 collaborators of Jill S. Frank. A scholar is included among the top collaborators of Jill S. Frank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill S. Frank. Jill S. Frank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Characterization of the CpG Island Hypermethylated Phenotype Subclass in Primary Melanomas 2021 ·Journal of Investigative Dermatology ·Kathleen Conway, Yi‐Hsuan Tsai, Sharon N. Edmiston, Joel S. Parker, Eloise Parrish, Honglin Hao, Pei Fen Kuan, Glynis Scott, Jill S. Frank, Paul B. Googe, David W. Ollila, Nancy E. Thomas	8
2	Expression of tryptophan metabolizing enzymes (TMEs) and its transporter, LAT1, in metastatic melanoma (MM): Prognostic and therapeutic implications. 2019 ·Journal of Clinical Oncology ·Dimitri G. Trembath, Paul B. Googe, Jill S. Frank, Madeline H. Kowalski, (unknown), (unknown), J. Ashley Ezzell, Nancy E. Thomas, David W. Ollila, Stergios J. Moschos	1
3	Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis 2018 ·Journal of Investigative Dermatology ·Kathleen Conway, Sharon N. Edmiston, Joel S. Parker, Pei Fen Kuan, Yi‐Hsuan Tsai, Pamela A. Groben, Daniel C. Zedek, Glynis Scott, Eloise Parrish, Honglin Hao, (unknown), Jill S. Frank, Craig C. Carson, Matthew D. Wilkerson, Xiaobei Zhao, (unknown), Stergios J. Moschos, David W. Ollila, Nancy E. Thomas	25
4	Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis 2018 ·American Journal of Dermatopathology ·Nancy E. Thomas, Sharon N. Edmiston, Yi‐Hsuan Tsai, Joel S. Parker, Paul B. Googe, Klaus J. Busam, Glynis Scott, Daniel C. Zedek, Eloise Parrish, Honglin Hao, (unknown), (unknown), Jill S. Frank, Pei Fen Kuan, David W. Ollila, Kathleen Conway	26
5	RX-3117, a novel hypomethylating agent, shows promising therapeutic activity in combination with nab-paclitaxel and check-point inhibitors in preclinical models 2017 ·Annals of Oncology ·Jill S. Frank, (unknown), (unknown), Ely Benaim	2
6	Tumor Mitotic Rate and Association with Recurrence in Sentinel Lymph Node Negative Stage II Melanoma Patients 2017 ·The American Surgeon ·Shachar Laks, Michael O. Meyers, Allison M. Deal, Jill S. Frank, Karyn B. Stitzenberg, Jen Jen Yeh, Nancy E. Thomas, David W. Ollila	8
7	Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma 2014 ·The American Journal of Surgery ·Justin Baker, Michael O. Meyers, Jill S. Frank, Keith D. Amos, Karyn B. Stitzenberg, David W. Ollila	28
8	Relative value unit impact of complex skin closures to academic surgical melanoma practices 2012 ·The American Journal of Surgery ·(unknown), Michael O. Meyers, Jen Jen Yeh, Keith D. Amos, Jill S. Frank, (unknown), David W. Ollila	5
9	Early Recurrence in Sentinel Lymph Node Positive Stage III Melanoma Patients 2012 ·The American Surgeon ·Justin Baker, David W. Ollila, Allison M. Deal, Jill S. Frank, Keith D. Amos, Michael O. Meyers	3
10	Age and Breslow Depth Are Associated with a Positive Sentinel Lymph Node in Patients with Cutaneous Melanocytic Tumors of Uncertain Malignant Potential 2010 ·Journal of the American College of Surgeons ·Michael O. Meyers, Jen Jen Yeh, Allison M. Deal, (unknown), John T. Woosley, Jill S. Frank, (unknown), Keith D. Amos, David W. Ollila	8
11	Metastatic Melanoma Cells in the Sentinel Node Cannot Be Ignored 2009 ·Journal of the American College of Surgeons ·David W. Ollila, Jean Ashburn, Keith D. Amos, Jen Jen Yeh, Jill S. Frank, Allison M. Deal, (unknown), (unknown), Michael O. Meyers	18
12	Utility of routine PET/CT and MRI staging in patients with sentinel lymph node positive melanoma 2009 ·Journal of Clinical Oncology ·Michael O. Meyers, Jen Jen Yeh, Keith D. Amos, (unknown), Jill S. Frank, David W. Ollila	3
13	Sentinel node biopsy performed in the neoadjuvant setting for breast cancer: results from the I-SPY TRIAL (CALGB 150007/150012 & ACRIN 6657). 2009 ·Cancer Research ·(unknown), (unknown), David Moore, Angela DeMichele, (unknown), (unknown), Jill S. Frank, Helen Krontiras, Leslie L. Montgomery, Venetia Sarode, Gloria Broadwater, (unknown), (unknown)	2
14	Staged sentinel lymph node biopsy before mastectomy facilitates surgical planning for breast cancer patients 2005 ·The American Journal of Surgery ·Nancy Klauber‐DeMore, Benjamin F. Calvo, C. Scott Hultman, Han Jo Kim, Michael O. Meyers, (unknown), Jill S. Frank, (unknown), Carolyn I. Sartor, David W. Ollila	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact